Pacer Advisors Inc. reduced its stake in Corteva, Inc. (NYSE:CTVA – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,353,734 shares of the company’s stock after selling 88,443 shares during the quarter. Pacer Advisors Inc. owned 0.35% of Corteva worth $157,771,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Harris Associates L P boosted its position in shares of Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after buying an additional 10,675,052 shares during the period. Norges Bank purchased a new stake in shares of Corteva in the 4th quarter valued at $504,001,000. Northwestern Mutual Wealth Management Co. lifted its stake in Corteva by 6,527.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock worth $211,025,000 after acquiring an additional 3,100,709 shares in the last quarter. Perpetual Ltd boosted its holdings in Corteva by 78,688.5% during the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after acquiring an additional 2,612,459 shares during the period. Finally, Amundi boosted its holdings in Corteva by 125.3% during the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after acquiring an additional 1,899,248 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.
Analyst Ratings Changes
CTVA has been the topic of a number of recent research reports. Oppenheimer boosted their price target on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. The Goldman Sachs Group raised their price objective on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. Berenberg Bank lifted their price objective on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Morgan Stanley upped their target price on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Finally, CICC Research increased their target price on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $88.81.
Corteva Price Performance
Shares of NYSE CTVA opened at $78.57 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The company has a market cap of $52.55 billion, a price-to-earnings ratio of 46.22, a price-to-earnings-growth ratio of 2.37 and a beta of 0.57. The stock’s 50-day moving average is $79.74 and its two-hundred day moving average is $75.67. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63.
Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter last year, the business posted $1.13 EPS. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is currently 42.35%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Stories
- Five stocks we like better than Corteva
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
